Recent Updates
Recently added Catalysts
VNDA Positive Sentiment

Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025

Wednesday, October 22, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Vanda Pharmaceuticals Inc. has announced the date for releasing its third quarter 2025 financial results, scheduled for October 29, 2025, after market close. Following the release, a conference call will be held at 4:30 PM ET where management will discuss the results and other corporate activities. The call will be accessible via phone and streamed on the company's website, with a replay available for a week following the event.
Price reaction · baseline $5.29 (2025-10-21 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close · peak
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Vanda will provide updates on its financial performance.
  • The conference call allows for direct communication with management.
  • Access to archived audio and replay increases investor engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Conference Call and Webcast to Follow
WASHINGTON, Oct. 22, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2025 on Wednesday, October 29, 2025, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, October 29, 2025, during which management will discuss the third quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 8728050.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, October 29, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, November 5, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8728050.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies

Frequently Asked Questions

When are Vanda's Q3 2025 results being released?

Vanda will release its Q3 2025 results on October 29, 2025, after market close.

How can I join the conference call?

To join, dial 1-888-596-4144 domestically or 1-646-968-2525 internationally.

What time is the Vanda conference call?

The conference call is scheduled for 4:30 PM ET on October 29, 2025.

Where can I find the conference call replay?

The replay will be available starting October 29, 2025, at 8:30 PM ET.

What is the passcode for the replay?

The passcode for the replay is 8728050.

ShareAdd on Google
Tags: VNDA Viatris Investor Conferences Healthcare Vanda Pharmaceuticals financial results Q3 2025 conference call
Last updated: Oct 22, 2025

Biotech snapshot

Cash runway
$170M liquidity · $10M/mo burn
~16 mo
Low dilution risk
Lead asset
ImsidolimabPhase 2
Palmoplantar Pustulosis →

Catalyst track record

+121%
best trade around VNDA's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for VNDA.

See every catalyst's timing & PoA →